Study of Comparison the Treatment Effect Between Gastric Bypass and Exenatide in Type 2 Diabetes

NCT01435980 · Unknown status

Last updated 2026-05-28

This clinical trial compares two treatments—gastric bypass surgery and the medication exenatide—in adults with type 2 diabetes to see which is more effective.

Status Unknown status The sponsor has not confirmed the status recently.

Phase Phase 4 Monitors a drug already on the market.

Type Interventional (clinical trial)

Design Randomized, open-label (no blinding) treatment study

Participants 60 people Planned (estimated).

Who can join Ages 18–60 · all sexes

Timeline Started 2008-02 · est. completion 2016-02

Where 1 site · China

What this study is testing ClinicalTrials.gov NCT01435980 ↗

Description as written by the study sponsor.

Objectives: To investigate the treatment effect between Gastric Bypass and Exenatide in Type 2 Diabetes in our hospital, in order to investigate the possible mechanism of Gastric Bypass and Exenatide.

Treatments tested

Gastric Bypass also known as basal treatment + Gastric Bypass Procedure

basal treatment and Gastric Bypass
Exenatide also known as basal treatment + Exenatide Drug

basal treatment and Exenatide

Main thing measured	Clinical events
Sponsor	Wu Qinan
Conditions studied	Type 2 Diabetes
GLP-1 drugs	exenatide

Full protocol, eligibility, and contacts on ClinicalTrials.gov NCT01435980 ↗